Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Archivos de la Sociedad Española de Oftalmología
versión impresa ISSN 0365-6691
Resumen
BARBON, J.J. et al. Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy. Arch Soc Esp Oftalmol [online]. 2007, vol.82, n.11, pp.715-717. ISSN 0365-6691.
Case report: We report a case of a patient diagnosed with prostatic adenocarcinoma with multiple bone metastases and a choroidal metastasis in his left eye. Hormonal therapy with an anti-androgen and a LH-RH agonist was followed by regression of the choroidal mass over a period of 2 months. No metastatic recurrence has been demonstrated after a follow-up period of 14 months. Discussion: Complete resolution of choroidal metastases of prostatic adenocarcinoma with hormonal therapy is exceptional, but the effect of this treatment on such metastases should be observed before recommending radiation therapy.
Palabras clave : Prostate adenocarcinoma; choroidal neoplasms; uveal neoplasms; metastasis; hormonal antineoplastic agents.